Impact of Selective Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) on Molecular Pathways and Correlated Clinical Response in Patients With Active Psoriatic Arthritis.
- DOI
- 10.1002/acr2.90124
- Published
- 2026 Sep
- Container
- ACR open rheumatology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/acr2.90124,
title = {Impact of Selective Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) on Molecular Pathways and Correlated Clinical Response in Patients With Active Psoriatic Arthritis.},
author = {Choudhury A and Cheng J and Tang J and Kumar S and Saha B and Arunachalam V and Hong T and Mark E and Wennbo H and McInnes IB},
year = {2026},
journal = {ACR open rheumatology},
doi = {10.1002/acr2.90124},
url = {https://doi.org/10.1002/acr2.90124}
}RIS
TY - JOUR TI - Impact of Selective Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) on Molecular Pathways and Correlated Clinical Response in Patients With Active Psoriatic Arthritis. AU - Choudhury A AU - Cheng J AU - Tang J AU - Kumar S AU - Saha B AU - Arunachalam V AU - Hong T AU - Mark E AU - Wennbo H AU - McInnes IB PY - 2026 JO - ACR open rheumatology DO - 10.1002/acr2.90124 UR - https://doi.org/10.1002/acr2.90124 ER -
APA
A, C., J, C., J, T., S, K., B, S., V, A., T, H., E, M., H, W., & IB, M. (2026). Impact of Selective Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) on Molecular Pathways and Correlated Clinical Response in Patients With Active Psoriatic Arthritis.. ACR open rheumatology. https://doi.org/10.1002/acr2.90124
Source records
- pubmed · retrieved 2026-09-26T20:18:24.786Z